Bioventix - Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

Registrars:

Key Personnel

CEO: Peter John Harrison
CFO: Bruce Hiscock
Chairman: Ian James Nicholson
Independent Non-Executive Director: Joanne (Jo) Pisani, Nicholas (Nick) John McCooke

Contact Details

Address: 27-28 Eastcastle Street, London, United Kingdom
Phone:
Fax:
Website: http://www.bioventix.com
Email:

Listings

ISIN: GB00B4QVDF07
Sector: Pharma and Biotech, Pharma and Biotech
Main Indices: FTSE AIM All-Share, FTSE AIM 100